A new trading day began on Monday, with Werewolf Therapeutics Inc (NASDAQ: HOWL) stock price down -8.87% from the previous day of trading, before settling in for the closing price of $2.48. HOWL’s price has ranged from $1.66 to $8.19 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 5.40% over the past five years. Meanwhile, its annual earnings per share averaged -53.81%. With a float of $32.07 million, this company’s outstanding shares have now reached $39.11 million.
Let’s look at the performance matrix of the company that is accounted for 47 employees. In terms of profitability, gross margin is 80.36%, operating margin of -628.41%, and the pretax margin is -578.8%.
Werewolf Therapeutics Inc (HOWL) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Werewolf Therapeutics Inc is 26.61%, while institutional ownership is 58.46%.
Werewolf Therapeutics Inc (HOWL) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -53.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.90% during the next five years compared to -13.31% drop over the previous five years of trading.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Trading Performance Indicators
Here are Werewolf Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.35, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.92 in one year’s time.
Technical Analysis of Werewolf Therapeutics Inc (HOWL)
Werewolf Therapeutics Inc (NASDAQ: HOWL) saw its 5-day average volume 0.66 million, a positive change from its year-to-date volume of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 11.18%. Additionally, its Average True Range was 0.31.
During the past 100 days, Werewolf Therapeutics Inc’s (HOWL) raw stochastic average was set at 23.81%, which indicates a significant increase from 13.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 190.80% in the past 14 days, which was higher than the 115.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.27, while its 200-day Moving Average is $4.00. Nevertheless, the first resistance level for the watch stands at $2.39 in the near term. At $2.53, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.59. If the price goes on to break the first support level at $2.19, it is likely to go to the next support level at $2.13. Assuming the price breaks the second support level, the third support level stands at $1.99.
Werewolf Therapeutics Inc (NASDAQ: HOWL) Key Stats
With a market capitalization of 95.87 million, the company has a total of 43,702K Shares Outstanding. Currently, annual sales are 19,940 K while annual income is -37,370 K. The company’s previous quarter sales were 1,140 K while its latest quarter income was -17,250 K.
